TFRC and amyotrophic lateral sclerosis: In amyotrophic lateral sclerosis (ALS), elevated ferritin and transferrin receptor levels in cerebrospinal fluid have been associated with reduced survival, suggesting that disrupted iron metabolism may serve as both a biomarker and a therapeutic target.